Additionally, if an actionable mutation was identified from circulating‐tumor DNA and no PD‐L1 expression was available from tissue, 30% of specialists reported “never obtaining a fresh tissue biopsy, even when possible” compared with only 8% of generalists (p = 0.001). This evidence concerns the gene CD274 and neoplasm.